Virus Briefing: Flawed pandemic plans

New infectious threats are coming. The U.S. probably won't contain them.
The New York Times

September 30, 2022

Here's your update on the coronavirus pandemic and other virus news.

OTHER NEWS

Article Image

Jamie Kelter Davis for The New York Times

Half of Adults Have Heard Little or Nothing About New Covid Boosters, Survey Finds

The latest shots, which target Omicron and its subvariants, could offer protection against a winter surge in cases. But many people are unsure if they're eligible.

By Jan Hoffman

Article Image

Charles Rex Arbogast/Associated Press

Physician Burnout Has Reached Distressing Levels, New Research Finds

Nearly two-thirds of doctors are experiencing at least one symptom of burnout, a huge increase from before the pandemic. But the situation is not irreparable, researchers say.

By Oliver Whang

Article Image

Phil Fisk/Sky Atlantic

Britain Wonders, Is It Too Soon to Dramatize the Pandemic?

A new Sky Atlantic mini-series, "This England," depicts the early days of Covid-19 in the country, with Kenneth Branagh playing Boris Johnson.

By Mark Landler

Article Image

Gilles Sabrié for The New York Times

China's 'Absurd' Covid Propaganda Stirs Rebellion

The use of propaganda in the country has been on overdrive in the pandemic, with some Chinese citizens arguing the language has bordered on "nonsense."

By Zixu Wang

Article Image

Getty Images

China Gets Its First mRNA Vaccine Approval. In Indonesia.

Indonesia has cleared an mRNA Covid-19 vaccine developed by a Chinese company. But those types of shots, considered among the most effective, aren't yet available in China.

By Alexandra Stevenson

What else we're following

The legacy of Covid-19

International Covid news

Monkeypox

  • Ohio officials said an individual with monkeypox died, the third known death of a person with the virus in the U.S., CNN reported.

Bird flu

Email your thoughts to virusbriefing@nytimes.com. Did a friend forward you the briefing? Sign up here.

Need help? Review our newsletter help page or contact us for assistance.

You received this email because you signed up for Virus Briefing from The New York Times.

To stop receiving these emails, unsubscribe or manage your email preferences.

Subscribe to The Times

Connect with us on:

facebooktwitterinstagram

Change Your EmailPrivacy PolicyContact UsCalifornia Notices

The New York Times Company. 620 Eighth Avenue New York, NY 10018

No comments:

Post a Comment